Browse Category

China News 10 February 2025 - 19 June 2025

China’s 2025 Drone Law Shockers: Strict Rules, No-Fly Zones & Big Penalties

China’s 2025 Drone Law Shockers: Strict Rules, No-Fly Zones & Big Penalties

Starting January 1, 2024, all drones in China must be registered under the owner’s real name with the CAAC on shine.cn, and a QR code sticker is issued after registration. Foreign tourists must register their drones before flying, with registration tied to a Chinese phone number, and an English portal was reportedly launched in 2025. Recreational pilots of small drones…
China’s EV Revolution: From $5,000 Minis to 1,000-km Supercars – How China Is Shocking the Global Car Market

China’s EV Revolution: From $5,000 Minis to 1,000-km Supercars – How China Is Shocking the Global Car Market

China produced over 11–13 million electric cars in 2024, about half of all new cars sold in the country, and accounted for roughly 58–70% of global EV output. BYD Auto became the world’s largest EV producer, accounting for about one‑third of China’s EV sales and surpassing Tesla’s global volumes in 2024. NIO’s ET7 offers up to 1,000 km of range…
Internet Access in China

Internet Access in China

By the end of 2023, about 1.09 billion Chinese residents were online (roughly 77.5% of the population), with over 99% of users accessing the net via mobile phones. China’s three major Internet Service Providers are China Telecom (state-owned, dominant in southern China), China Unicom (state-owned, dominant in northern regions), and China Mobile (the largest mobile operator, dominant in central and…
10 February 2025

Stock Market Today

  • Novartis (SWX:NOVN) Seen Undervalued Despite Strong Multi-Year Gains
    January 31, 2026, 11:19 AM EST. Novartis shares trade around $114.62 after a 0.9% pullback in the past week and a 1-year return of 24.2%, lagging peers. The pharmaceutical giant boasts 70.3% returns over three years and 80% over five years. Our Discounted Cash Flow (DCF) model, projecting future cash flows until 2030, values Novartis stock at $254.07 per share, suggesting a 54.9% undervaluation versus the current price. With free cash flow projected to rise from $18.2 billion to $21.2 billion by 2030, the company's valuation looks attractive. The price-to-earnings (P/E) ratio complements this view, linking share price to earnings growth and risk. Novartis scores 5 out of 6 on undervaluation metrics, supporting the case for potential entry or hold for investors.
Go toTop